Enzo Biochem (ENZ)
(Delayed Data from NYSE)
$1.11 USD
-0.02 (-1.77%)
Updated Sep 13, 2024 04:00 PM ET
After-Market: $1.12 +0.01 (0.90%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
ENZ 1.11 -0.02(-1.77%)
Will ENZ be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ENZ based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ENZ
Zacks Initiates Coverage of Enzo Biochem With Neutral Recommendation
Enzo Biochem (ENZ) Q3 Earnings Improve Y/Y, Gross Margin Up
ENZ: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for ENZ
Enzo Biochem penalized $4.5M over data breach
Rare Stock Picks In July 2024 - From 29 Discerning Analysts
Enzo Biochem Board Member Resigns to Pursue New Opportunities
Enzo Biochem: Is This Time Finally Different?
What You Missed On Wall Street This Morning